高级检索
当前位置: 首页 > 详情页

Ginsenoside (20S)-protopanaxatriol induces non-protective autophagy and apoptosis by inhibiting Akt/mTOR signaling pathway in triple-negative breast cancer cells.

文献详情

资源类型:
Pubmed体系:
机构: [a]College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, 510630, PR China [b]First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, 510630, PR China [c]Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization Jinan University, Guangzhou, Guangdong, 510630, PR China [d]College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510630, PR China [e]Cancer Research Institute, Jinan University, Guangzhou, Guangdong, 510630, PR China [f]Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong, 528000, PR China
出处:
ISSN:

关键词: Triple negative breast cancer (TNBC) (20S)-Protopanaxatriol Autophagy Apoptosis Akt/mTOR signaling pathway

摘要:
Triple-negative breast cancer (TNBC) lacks a recognized therapeutic molecular target and has an unfavorable prognosis. (20S)-Protopanaxatriol (g-PPT, PPT) is an active metabolite extracted from ginseng. Accumulating evidence suggests that it has good anti-cancer activity in vivo and in vitro. In this study, we aimed to elucidate the anti-tumor effects of PPT in TNBC cells and tumor-bearing mice, as well as the relevant molecular mechanisms of autophagy and apoptosis. In vitro, we have found that PPT is capable of inducing non-protective autophagy and apoptosis, thus exerting some anti-proliferative and anti-migration activity in TNBC cells. And in vivo, the therapeutic effects of PPT were evaluated by xenograft mouse models. The potential binding mode of PPT and Akt was predicted by molecular docking. Our findings indicated that PPT treatment induced non-protective autophagy in TNBC cells by inhibiting the Akt/mTOR signaling pathway. Therefore, PPT may be a potential treatment for TNBC in the future.Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 生物
小类 | 3 区 生物物理 4 区 生化与分子生物学
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 生化与分子生物学 4 区 生物物理
第一作者:
第一作者机构: [a]College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, 510630, PR China
共同第一作者:
通讯作者:
通讯机构: [b]First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, 510630, PR China [c]Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization Jinan University, Guangzhou, Guangdong, 510630, PR China [d]College of Pharmacy, Jinan University, Guangzhou, Guangdong, 510630, PR China [*1]First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, 510630, PR China. [*2]Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, Jinan University, Guangzhou, Guangdong, 510630, PR China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号